PCM
PAHC icon

Piermont Capital Management’s Phibro Animal Health PAHC Stock Holding History

Piermont Capital Management’s Portfolio PAHC Stock Details PAHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-4,770
Closed -$220K – 184
2018
Q2 		$220K Sell
4,770
-840
-15% -$37.2K 0.07% 228
2018
Q1 		$223K Buy
+5,610
New +$208K 0.07% 229

Other funds holding PAHC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CVA
Ceredex Value Advisors Orlando, Florida $3.18B AUM 35.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
FIM
Foresters Investment Management New York $5.05B AUM 5.06% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return

Piermont Capital Management's PAHC Position: Q3 2018 in Review

Piermont Capital Management sold out of Phibro Animal Health (PAHC) in Q3 2018, closing a stake of 4,770 shares — an estimated $220K sold.

Piermont Capital Management first reported a position in PAHC in Q1 2018 and held it in 2 quarters. The position peaked at $223K in Q1 2018. 191 funds tracked by Wall St. Rank hold PAHC as of Q3 2018.

  • Piermont Capital Management reported no remaining Phibro Animal Health position as of Q3 2018 after selling out during the quarter.
  • Piermont Capital Management sold 4,770 Phibro Animal Health shares in Q3 2018, an estimated $220K.
  • Piermont Capital Management first reported a position in Phibro Animal Health in Q1 2018 and held it in 2 quarters.
  • Piermont Capital Management's Phibro Animal Health position peaked at $223K in Q1 2018.
  • 191 funds tracked by Wall St. Rank held Phibro Animal Health as of Q3 2018.

Based on Piermont Capital Management's 13F filing for Q3 2018, filed 6 Nov 2018.